DACH1 Antibody

1. DACH1 expression is decreased in glomerulopathy imply a potential role for DACH1 in the this development of human chornic glomerulopathy. PMID: 27888806
2. Knockdown of DACH1 expression can remarkably enhance the cell apoptosis, restrain the proliferation, migration and invasion of Capan-1 cells. PMID: 27609579
3. DACH1 expression regulates the pancreatic cancer cell apoptosis. PMID: 27278537
4. Low DACH1 expression is associated with invasion of lung adenocarcinoma. PMID: 26810067
5. This study concludes that MiR-217 is the upstream regulator of PGC-1alpha in breast cancer regulation in vitro, possibly independent of DACH1 signaling pathway. PMID: 27916422
6. Kaplan-Mier analysis of human NSCLC samples demonstrated that high DACH1 mRNA levels predicted favorable prognosis for relapse-free and overall survival. In agreement, high CXCL5 expression predicted a worse prognosis for survival. PMID: 25788272
7. DACH1 expression was reduced in hepatocellular carcinoma even at early stage and associated with tumor progression. Overexpression inhibited HCC cell growth and migration by inactivating the Wnt pathway via GSK3beta phosphorylation to suppress beta-catenin. PMID: 25940701
8. In breast cancer, some GATA3 effects shift from tumor suppressing to tumor promoting during tumorigenesis, with deregulation of three genes, BCL2, DACH1, THSD4, representing major GATA3-controlled processes in cancer progression. PMID: 25410484
9. Results indicated that DACH1 was a novel molecular marker of RCC and it attributed to the malignant behavior of renal cancer cells. PMID: 25322986
10. Data indicate that dachshund family transcription factor 1 (DACH1) suppresses gastric cancer cell proliferation, invasion and metastasis by inhibiting transforming growth factor beta (TGF-beta) signalling pathways both in vitro and in vivo. PMID: 24912879
11. results suggest that DACH1 loss of function results in increased cell growth, motility and invasiveness through TGF-beta-mediated EMT, and DACH1 loss of function has important therapeutic implications for targeted therapies of CRC PMID: 25778865
12. DACH1 is a determinant of benign and malignant prostate epithelium cellular growth, migration, and cytokine abundance in vivo. PMID: 25769723
13. Further evaluation of the methylation of DACH1, DKK1, and WIF1 in a clinical patient group confirmed the frequent methylation of WIF1 and intermediate or low frequency of methylation of DACH1 or DKK1, respectively. PMID: 25487617
14. DACH1 inhibits aldosterone secretion in human adrenals, and transforming growth factor-beta signaling pathway is activated in DACH1 overexpressed cells and may mediate inhibition of aldosterone secretion in human adrenals. PMID: 25776071
15. Familial young-onset diabetes, pre-diabetes and cardiovascular disease are associated with genetic variants of DACH1 in Chinese PMID: 24465431
16. Nuclear DACH1 expression appears to be a Luminal A biomarker predictive of good prognosis, but is not independent of clinical stage, tumour size, NPI status or systemic therapy. PMID: 24392136
17. DACH1 is frequently methylated in human colorectal cancers (CRC) and methylation of DACH1 may serve as detective and prognostic marker in CRC. PMID: 24149323
18. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation. PMID: 24335958
19. DACH1 binds p53 to inhibit NSCLC cellular growth. PMID: 23492369
20. DACH1 gene promoter methylation could lead to a decrease or absence of DACH1 expression in endometrial carcinoma. PMID: 22781112
21. the inability of C/EBPalpha and GATA-1 to down-regulate DACH1 expression induced by MLL-AF9 during myeloid differentiation may contribute to t(9;11) leukemogenesis. PMID: 22902925
22. DACH1 is highly expressed in metastatic ovarian cancer compared with that of normal, benign, and borderline ovarian tissues and could play an important role in cancer growth. PMID: 22367319
23. The knockdown of DACH1 blocked the cell cycle progression of HL-60 promyeloblastic cells through the decrease of cyclin D1, D3, F, and Cdk 1, 4, and 6 and increase in p21(Cip1), which in turn decreased the phosphorylation of the Rb protein. PMID: 22405764
24. in cells growing in IGF-1 (and unresponsive to EGF), DACH1 is devoid of tumor suppressor activity. PMID: 21558809
25. DACH1 is a distinctive tumor suppressor, which not only suppresses growth of tumor cells but also regulates bFGF-mediated tumor-initiating activity of glioma cells PMID: 21750150
26. DACH1 represses gene transcription through direct DNA binding to the promoter region of target genes by recruiting the transcriptional co-regulator, TCERG1. PMID: 20956529
27. Forkhead signaling is attenuated by the retinal determination factor DACH1 PMID: 20351289
28. The altered expression of human DACH1 has been associated with tumor progression and metastasis. DACH1 inhibits breast cancer cellular proliferation via cyclin D1. PMID: 19502783
29. Findings identify a role of EYA4 and possibly interacting SIX and DACH proteins in MPNSTs and suggest the EYA4 pathway as a rational therapeutic target. PMID: 19901965
30. forms an alpha/beta structure containing a DNA binding motif similar PMID: 12057194
31. DACH1 bound to endogenous NCoR and Smad4 in cultured cells; Smad4 was required for DACH1 repression of TGF-beta induction of Smad signaling PMID: 14525983
32. identifed DACH enhancers in gene deserts PMID: 14563999
33. The dachshund is required in mushroom body neurons for proper axon guidance and branching in Drosophila melanogaster. PMID: 15818552
34. DACH1 repressed cyclin D1 through a novel mechanism via a c-Jun DNA-binding partner, requiring the DACH1 alpha-helical DS domain which recruits corepressors to the local chromatin. PMID: 16980615
35. DACH1 plays an important role in negative regulation of RANKL gene expression in marrow stromal/preosteoblast cells in the bone microenvironment. PMID: 17891780
36. These data identify a pathway by which an endogenous cell-fate determination factor blocks oncogene-dependent tumor metastasis via a key heterotypic mediator. PMID: 18467491
37. DACH1 is hypermethylated in renal cell carcinoma. PMID: 18639284
38. a statistical significance level for DACH1 in gastric cancer PMID: 18957060
39. DACH1 inhibited ligand-dependent activity of AR mutations identified in patients with androgen-insensitive prostate cancer. The DS domain was sufficient for repression of the AR wild-type but failed to repress an AR acetylation site point mutant. PMID: 19351840
40. Data show that DACH1 expression, which is lost in poor prognosis human breast cancer, functions as an endogenous inhibitor of ERalpha function. PMID: 19605405

Show More

Hide All

HGNC: 2663

OMIM: 603803

KEGG: hsa:1602

UniGene: Hs.129452